Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review.

Adam P Goode, Remy R Coeytaux, Gary R Maslow, Naomi Davis, Sherika Hill, Behrouz Namdari, Nancy M Allen LaPointe, Deanna Befus, Kathryn R Lallinger, Samantha E Bowen, Andrzej Kosinski, Amanda J McBroom, Gillian D Sanders, Alex R Kemper

Journal: Pediatrics 2019;141(6):e20180094

PMID: 29848556

Abstract

CONTEXT

Nonpharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) encompass a range of care approaches from structured behavioral interventions to complementary medicines.

OBJECTIVES

To assess the comparative effectiveness of nonpharmacologic treatments for ADHD among individuals 17 years of age and younger.

DATA SOURCES

PubMed, Embase, PsycINFO, and Cochrane Database of Systematic Reviews for relevant English-language studies published from January 1, 2009 through November 7, 2016.

STUDY SELECTION

We included studies that compared any ADHD nonpharmacologic treatment strategy with placebo, pharmacologic, or another nonpharmacologic treatment.

DATA EXTRACTION

Study design, patient characteristics, intervention approaches, follow-up times, and outcomes were abstracted. For comparisons with at least 3 similar studies, random-effects meta-analysis was used to generate pooled estimates.

RESULTS

We identified 54 studies of nonpharmacologic treatments, including neurofeedback, cognitive training, cognitive behavioral therapy, child or parent training, dietary omega fatty acid supplementation, and herbal and/or dietary approaches. No new guidance was identified regarding the comparative effectiveness of nonpharmacologic treatments. Pooled results for omega fatty acids found no significant effects for parent rating of ADHD total symptoms ( = 411; standardized mean difference -0.32; 95% confidence interval -0.80 to 0.15; I = 52.4%; = .10) or teacher-rated total ADHD symptoms ( = 287; standardized mean difference -0.08; 95% confidence interval -0.47 to 0.32; I = 0.0%; = .56).

LIMITATIONS

Studies often did not reflect the primary care setting and had short follow-up periods, small sample sizes, variations in outcomes, and inconsistent reporting of comparative statistical analyses.

CONCLUSIONS

Despite wide use, there are significant gaps in knowledge regarding the effectiveness of ADHD nonpharmacologic treatments.

Copyright © 2018 by the American Academy of Pediatrics.

Address: Duke Orthopaedic Surgery.; Duke Clinical Research Institute, and.; Department of Family and Community Medicine and.; Center of Integrative Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.; Departments of Psychiatry and Behavioral Sciences.; Pediatrics, and.; Medicine.; Premier, Inc, Charlotte, North Carolina.; Duke Evidence-Based Practice Center, Durham, North Carolina; and.; Duke Center for Autism and Brain Development, School of Medicine, Duke University, Durham, North Carolina.; Division of Ambulatory Pediatrics, Nationwide Children's Hospital, Columbus, Ohio [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.